EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M107. A total of 10 filers reported holding EYEGATE PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,000 | -50.0% | 5,000 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 5,000 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 5,000 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | -33.3% | 5,000 | -12.9% | 0.00% | – |
| Q2 2018 | $3,000 | 0.0% | 5,740 | -25.7% | 0.00% | – |
| Q1 2018 | $3,000 | +200.0% | 7,721 | +943.4% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 740 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 740 | -39.3% | 0.00% | – |
| Q2 2017 | $1,000 | -83.3% | 1,220 | -42.3% | 0.00% | – |
| Q1 2017 | $6,000 | +200.0% | 2,116 | +43.0% | 0.00% | – |
| Q4 2016 | $2,000 | +100.0% | 1,480 | +100.0% | 0.00% | – |
| Q3 2016 | $1,000 | -66.7% | 740 | -38.3% | 0.00% | – |
| Q2 2016 | $3,000 | -81.2% | 1,199 | -77.4% | 0.00% | – |
| Q1 2016 | $16,000 | +14.3% | 5,299 | -0.2% | 0.00% | – |
| Q4 2015 | $14,000 | +366.7% | 5,312 | +343.0% | 0.00% | – |
| Q3 2015 | $3,000 | – | 1,199 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|